drugset / Trial / NCT06453824
SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants
RandomizedSequentialTriple-blindTreatment
Summary
This is a Phase 1 study to test the safety and drug effects of MDI-2517 when given once in healthy volunteers.
Timeline
- Start
- 2024-05-17
- Primary completion
- 2024-11-11
- Completion
- 2024-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MDI-2517 | Unknown | — | Oral |
Indications
No indication recorded.